Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine

• Konstantinos Makris

  Konstantinos Makris, PhD, EurClinChem, graduated in Biology from Aristotelion University of Thessaloniki, Greece in 1981. From 1985 to 2002 he worked in the blood transfusion service of the KAT General Hospital in Athens, Greece. In 1996, he gained his PhD in laboratory hematology and transfusion medicine from the Medical School of the University of Patras, Greece, with a research project on transfusion transmitted hepatitis. From 2002 he worked in the Clinical Biochemistry Department of KAT General Hospital in Athens, Greece. He has been a member of the European Registry of Clinical Biochemists since 2003. His main research interests include biomarkers for cardiovascular, renal and metabolic diseases. He has several publication in the fields of clinical biochemistry and transfusion medicine and is also a reviewer for Clinical Chemistry, JACC, and Journal of Translational Medicine.

  , Demetrios Rizos

  Demetrios A. Rizos, Assistant Professor of Clinical Chemistry, 2nd Department of Obstetrics and Gynecology, Medical School, University of Athens, Greece. He is the Scientific Director of the “Hormone” Laboratory, “Aretaieio” Hospital. He has been the President of the Greek Society of Clinical Chemistry-Clinical Biochemistry and is currently the President of the Greek National Clinical Chemistry Registration Committee. He is author of 103 published papers in peer reviewed journals with more than 800 total citations.

  , Nikolaos Kafkas

  Nikolaos Kafkas, MD, PhD, FESC, graduated in medicine from University of Athens Greece in 1987. In 1997, he specialized in Cardiology at G. Genimatas General Hospital of Athens and in 2006 he specialized in interventional cardiology at Onaseion Cardiac Surgery Center of Athens, Greece. Currently he is working as a staff member of the Cardiology Department at KAT General Hospital in Athens, Greece. In 2008, he gained his PhD in Cardiology from the Medical School of the University of Athens, Greece, with a research project on the role of procalcitonin in coronary artery disease. He currently is the head of the intervention cardiology laboratory of the KAT general hospital. He has published several articles in peer review journals and presented in international congresses.

  and Alexander Haliassos

  Alexander Haliassos studied medicine at the National University of Athens (UoA), Greece. He continued his studies on electronics applied in the medical field and in human genetics at the Medical School of Claude Bernard University, Lyon, France. After his 2 years service as a Medical Doctor in the Greek Air Force he continued his studies as Post-doctoral fellow at the “Institut de Pathologie Moléculaire” of René Descartes University, Paris V, France where was trained in the new techniques of Molecular Biology. He obtained his PhD diploma on 1989 at the Medical School (UoA). From 1991 to 1993 he was Medical Doctor-Research fellow at the National Research Foundation, Institute for Biological Research and Biotechnology in Athens. He organized and directed subsequently the core laboratories (including the Blood Bank) of the Onassis Cardiac Surgery Center, the Athens Euroclinic and the Metropolitan Hospital at Athens. He obtained the title of European Clinical Chemist (EurClinChem) in 2003. He published more than 40 papers in peer-reviewed scientific journals, made more than 70 oral presentations and participated in 110 posters in international meetings.